Specifically, we aimed to identify whether increased OST48 in the presence of hyperglycaemia could drive AGE lowering to protect against AGE-mediated microvascular damage typically seen in DKD, such as glomerular pathology and greater tubulointerstitial fibrosis. This evidence concerns the gene DDOST and diabetic kidney disease.